HCS Market 2017
About HCS
High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples.
Technavio's analysts forecast the global HCS market to grow at a CAGR of 11.53% over the period 2014-2019.
Covered in this Report
Covered in this Report
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/69821-global-high-content-screening-hcs-market-2015-2019
The report includes the present scenario and the growth prospects of the global HCS market for the period 2015-2019. The market can be segmented into three customer segments: Pharmaceutical and biotechnology companies, academia and research institutes, and contract research organizations.
Technavio's report, Global HCS Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global HCS market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Technavio's report, Global HCS Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global HCS market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions • Americas
• APAC
• EMEA
Key Vendors • Becton, Dickinson and Company
• GE Healthcare
• Danaher
• PerkinElmer
• Thermo Fisher Scientific
Other Prominent Vendors • Blue Sky Bioservices
• Cell Signaling Technology
• Charles River Laboratories International
• Cytoo
• EMD Millipore
• Evotec
• Fluofarma
• Genedata
• Imagen Biotech
• Thorlabs
• Tecan
• Vala Sciences
• Wako Automation
• Yokogawa
Key Market Driver • Growing Importance of High Content Screening in Therapeutics
• For a full, detailed list, view our report
• For a full, detailed list, view our report
Key Market Challenge • Handling Large Amount of Data
• For a full, detailed list, view our report
Key Market Trend • Advances in Personalized Medicines
• For a full, detailed list, view our report
Key Questions Answered in this Report • What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://www.wiseguyreports.com/reports/69821-global-high-content-screening-hcs-market-2015-2019
Table of Contents
- Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Key Developments
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by End-User
09. Geographical Segmentation
09.1 Segmentation of Global HCS Market by Region
09.2 HCS Market in Americas
09.2.1 Market Size and Forecast
09.3 HCS Market in EMEA
09.3.1 Market Size and Forecast
09.4 HCS Market in APAC
09.4.1 Market Size and Forecast
10. Buying Criteria
11. Market Drivers
12. Drivers and Their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and Their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 BD
17.2.2 GE Healthcare
17.2.3 Molecular Devices (Subsidiary of Danaher)
17.2.4 PerkinElmer
17.2.5 Thermo Fisher Scientific
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Becton, Dickinson and Co.
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Revenue Segmentation by Business
18.1.5 Segmental Revenue Comparison 2013 and 2012
18.1.6 Revenue Segmentation by Region
18.1.7 Business Strategy
18.1.8 Key Developments
18.1.9 SWOT Analysis
18.2 GE Healthcare
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Business Strategy
18.2.5 Key Developments
18.2.6 SWOT Analysis
18.3 Danaher
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation
18.3.4 Revenue by Business Segmentation
18.3.5 Revenue Comparison 2012 and 2013
18.3.6 Segmentation by Region
18.3.7 Business Strategy
18.3.8 Key Information
18.3.9 SWOT Analysis
18.4 PerkinElmer
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Business Segmentation
18.4.4 Business Strategy
18.4.5 Revenue Segmentation by Business
18.4.6 Key Developments
18.4.7 SWOT Analysis
18.5 Thermo Fisher Scientific
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation by Revenue 2014
18.5.4 Business Segmentation by Revenue 2013 and 2014
18.5.5 Geographical Segmentation by Revenue 2014
18.5.6 Business Strategy
18.5.7 Recent Developments
18.5.8 SWOT Analysis
19. Other Reports in This Series
Continued…….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment